Asian innovation in pharmaceutical and medical device industry – beyond tomorrow

Figures & data

Graph 1. Health care spending (USD billion). Source: The Economic Intelligence Unit.

Graph 2. Comparison of the proportion of residents' medical payment.

Graph 3. Comparison of the proportion of Chinese residents' medical payment. Source: Based on data from the World Health Organization Committee, the World Bank, the National Health Commission, the National Medical Security Administration, and the People's Bank of China.

Table 1. Percentage of healthcare professionals who currently use any digital health technology or mobile health apps.

Country	Percentage	Country	Percentage
France	79	Brazil	75
UK	72	Saudi Arabia	85
Netherlands	86	India	88
Germany	64	South Africa	48
Poland	77	Singapore	82
Italy	88	Australia	76
Russia	81	China	94
US	76	15-country average	78

Data sources: Future Health Index 2019.

Table 2. The pharmaceutical industry is growing rapidly in Southeast Asia.

Country	2014 Pharma spending (2014–2019 CAGR)	Health care	Out-of-pocket spending (%)	Private insurance (%)
Vietnam	$3 billion (11%)	Nascent	51	11
Thailand	$7.5 billion (5%)	Maturing	21	12
Malaysia	$1.7 billion (8%)	Maturing	41	12
Philippines	$5.7 billion (10%)	Nascent	43	12
Indonesia	$9 billion (9%)	Nascent	37	25
Singapore	$1.2 billion (7%)	Mature	51	9

Source: Economist Intelligence Unit database.

Note: The maturity of various health care systems is defined by parameters described in Chongsuvivatwong et al.⁷² Private insurance is offered as a CAGR; the predictions are for life insurance, whole market, policies and premiums, and gross written premiums from 2015 through 2019.

Graph 4. Medtech, market size by region. Source: Health Research International.

Chongsuvivatwong V, Phua KH, Yap MT, et al. Health and health-care systems in Southeast Asia: diversity and transitions. Lancet. 2011;377(9763):429–437.

 PubMed Web of Science ®Google Scholar